[1] |
Qiu DM, Wang GL, Chen L, et al. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance[J]. BMC Cancer,2014,14:327. doi: 10.1186/1471-2407-14-327
|
[2] |
Gracia-Sancho J, Garcia-Caldero H, Hide D, et al. Simvastatin maintains function and viability of steatotic rat livers procured for transplantation[J]. J Hepatol,2013,58(6):1140-1146. doi: 10.1016/j.jhep.2013.02.005
|
[3] |
Pirenne J, Van Gelder F, Aerts R, et al. Abdominal Transplant Surgery and Transplant Coordination University Hospitals Leuven 1997-2007:an overview[J]. Acta Chir Belg,2008,108(1):15-21. http://cn.bing.com/academic/profile?id=1914626081&encoded=0&v=paper_preview&mkt=zh-cn
|
[4] |
Lee YJ, Hah YJ, Kang YN, et al. The autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinoma[J]. PLoS One,2013,8(11):e81540. doi: 10.1371/journal.pone.0081540
|
[5] |
喻琴琴,杨俊,李馨欣,等. 自噬及其抑制剂的研究进展[J].实用医学杂志,2013,29(17):2908-2910. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201317057.htm
Yu QQ, Yang J, Li XX, et al. Research progress of autophagy and its inhibitors[J]. J Pract Med,2013,29(17):2908-2910. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201317057.htm
|
[6] |
Ge YY, Shi Q, Zheng ZY, et al. MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R[J]. Oncotarget,2014,5(15):6218-6228. doi: 10.18632/oncotarget
|
[7] |
Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases[J]. Nat Rev Drug Discov,2012,11(9):709-730. doi: 10.1038/nrd3802
|
[8] |
Degenhardt K, Mathew R, Beaudoin B, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis[J]. Cancer Cell,2006,10(1):51-64. doi: 10.1016/j.ccr.2006.06.001
|
[9] |
Klionsky DJ, Cuervo AM, Seglen PO. Methods for monitoring autophagy from yeast to human[J]. Autophagy,2007,3(3):181-206. doi: 10.4161/auto.3678
|
[10] |
Massey AC, Zhang C, Cuervo AM. Chaperone-mediated autophagy in aging and disease[J]. Curr Top Dev Biol,2006,73:205-235. doi: 10.1016/S0070-2153(05)73007-6
|
[11] |
Wang Z, Han W, Sui X, et al. Autophagy:a novel therapeutic target for hepatocarcinoma (review)[J]. Oncol Lett,2014,7(5):1345-1351. http://cn.bing.com/academic/profile?id=1963805414&encoded=0&v=paper_preview&mkt=zh-cn
|
[12] |
Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response[J]. Mol Cell,2010,40(2):280-293. doi: 10.1016/j.molcel.2010.09.023
|
[13] |
Rosenfeldt MT, Ryan KM. The multiple roles of autophagy in cancer[J]. Carcinogenesis,2011,32(7):955-963. doi: 10.1093/carcin/bgr031
|
[14] |
Mizushima N. Autophagy:process and function[J]. Genes Dev,2007,21(22):2861-2873. doi: 10.1101/gad.1599207
|
[15] |
Yue Z. Regulation of neuronal autophagy in axon:implication of autophagy in axonal function and dysfunction/degeneration[J]. Autophagy,2007,3(2):139-141. doi: 10.4161/auto.3602
|
[16] |
Scharl M, Rogler G. Inflammatory bowel disease:dysfunction of autophagy?[J]. Dig Dis,2012,30(Suppl 3):12-19. http://cn.bing.com/academic/profile?id=2030929597&encoded=0&v=paper_preview&mkt=zh-cn
|
[17] |
Yamaguchi O, Otsu K. Role of autophagy in aging[J]. J Cardiovasc Pharmacol,2012,60(3):242-247. doi: 10.1097/FJC.0b013e31824cc31c
|
[18] |
Eskelinen EL. The dual role of autophagy in cancer[J]. Curr Opin Pharmacol,2011,11(4):294-300. doi: 10.1016/j.coph.2011.03.009
|
[19] |
张剑文,陈规划.关于边缘供肝移植的一点思考[J].器官移植,2014,(4):210-212. http://www.organtranspl.com/browse/detail/qkid/90/id/203.html
Zhang JW, Chen GH. Reflect on marginal donor liver transplantation[J]. Organ Transplant,2014,(4):210-212. http://www.organtranspl.com/browse/detail/qkid/90/id/203.html
|
[20] |
Theodoraki K, Tympa A, Karmaniolou I, et al. Ischemia/reperfusion injury in liver resection:a review of preconditioning methods[J]. Surg Today,2011,41(5):620-629. doi: 10.1007/s00595-010-4444-4
|
[21] |
Abu-Amara M, Yang SY, Tapuria N, et al. Liver ischemia/reperfusion injury:processes in inflammatory networks:a review[J]. Liver Transpl,2010,16(9):1016-1032. doi: 10.1002/lt.22117
|
[22] |
Kaushal GP. Autophagy protects proximal tubular cells from injury and apoptosis[J]. Kidney Int,2012,82(12):1250-1253. doi: 10.1038/ki.2012.337
|
[23] |
Zhang X, Yan H, Yuan Y, et al. Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance[J]. Autophagy,2013,9(9):1321-1333. doi: 10.4161/auto.25132
|
[24] |
Rautou PE, Mansouri A, Lebrec D, et al. Autophagy in liver diseases[J]. J Hepatol,2010,53(6):1123-1134. doi: 10.1016/j.jhep.2010.07.006
|
[25] |
Dong Y, Undyala VV, Gottlieb RA, et al. Autophagy:definition, molecular machinery, and potential role in myocardial ischemia-reperfusion injury[J]. J Cardiovasc Pharmacol Ther,2010,15(3):220-230. doi: 10.1177/1074248410370327
|
[26] |
Shen M, Lu J, Dai W, et al. Ethyl pyruvate ameliorates hepatic ischemia-reperfusion injury by inhibiting intrinsic pathway of apoptosis and autophagy[J]. Mediators Inflamm,2013,2013:461536. http://cn.bing.com/academic/profile?id=2094211752&encoded=0&v=paper_preview&mkt=zh-cn
|
[27] |
Minor T, Koetting M, Koetting M, et al. Hypothermic reconditioning by gaseous oxygen improves survival after liver transplantation in the pig[J]. Am J Transplant,2011,11(12):2627-2634. doi: 10.1111/j.1600-6143.2011.03731.x
|
[28] |
Tal MC, Sasai M, Lee HK, et al. Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling[J]. Proc Natl Acad Sci U S A,2009,106(8):2770-2775. doi: 10.1073/pnas.0807694106
|
[29] |
Degli ED, Sebagh M, Pham P, et al. Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes[J]. Cell Death Dis,2011,2:e111. doi: 10.1038/cddis.2010.89
|
[30] |
Minor T, Stegemann J, Hirner A, et al. Impaired autophagic clearance after cold preservation of fatty livers correlates with tissue necrosis upon reperfusion and is reversed by hypothermic reconditioning[J]. Liver Transpl,2009,15(7):798-805. doi: 10.1002/lt.v15:7
|
[31] |
Martinez-Mier G, Mendez-Lopez MT, Estrada-Oros J, et al. Conversion from calcineurin inhibitor to sirolimus for renal function deterioration in kidney allograft recipients[J]. Arch Med Res,2006,37(5):635-638. doi: 10.1016/j.arcmed.2005.12.003
|
[32] |
Takamura A, Komatsu M, Hara T, et al. Autophagy-deficient mice develop multiple liver tumors[J]. Genes Dev,2011,25(8):795-800. doi: 10.1101/gad.2016211
|
[33] |
Fouraschen SM, de Ruiter PE, Kwekkeboom J, et al. mTOR signaling in liver regeneration:rapamycin combined with growth factor treatment[J]. World J Transplant,2013,3(3):36-47. doi: 10.5500/wjt.v3.i3.36
|
[34] |
Wang C, Chen K, Xia Y, et al. N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway[J]. PloS One,2014,9(9):e108855. doi: 10.1371/journal.pone.0108855
|
[35] |
Battaglia M, Stabilini A, Migliavacca B, et al. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients[J]. J Immunol,2006,177(12):8338-8347. doi: 10.4049/jimmunol.177.12.8338
|
[36] |
Amarnath S, Flomerfelt FA, Costanzo CM, et al. Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD[J]. Autophagy,2010,6(4):523-541. doi: 10.4161/auto.6.4.11811
|
[37] |
Li C, Capan E, Zhao Y, et al. Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death[J]. J Immunol,2006,177(8):5163-5168. doi: 10.4049/jimmunol.177.8.5163
|
[38] |
Padrissa-Altes S, Zaouali MA, Bartrons R, et al. Ubiquitin-proteasome system inhibitors and AMPK regulation in hepatic cold ischaemia and reperfusion injury:possible mechanisms[J]. Clin Sci,2012,123(2):93-98. doi: 10.1042/CS20110093
|